Best Companies Logo.png
Best IVA Companies in the UK for 2024 Announced by Best-companies.co.uk to Alleviate Financial Strains in the New Year
December 21, 2023 09:00 ET | Best Companies
Manchester, England, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Best-companies.co.uk, a reliable online resource that compiles the best companies and brands in the UK, is pleased to announce it has released...
Asset-2.png
IVA4Me Publishes New Guide About Managing Unaffordable Debt With an IVA
July 26, 2023 09:00 ET | IVA4Me
Stockport, United Kingdom, July 26, 2023 (GLOBE NEWSWIRE) -- IVA4Me published a new guide about how people can manage unaffordable debt by using debt management solutions like IVA. Many people may...
Inventiva annonce qu
Inventiva annonce que son partenaire Sino Biopharm a reçu l'approbation de sa demande d’IND par la NMPA pour démarrer le développement clinique de lanifibranor en Chine
May 25, 2023 16:00 ET | INVENTIVA
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., filiale de Sino Biopharm, a reçu l'approbation de sa demande d’IND par la NMPA permettant l’initiation du développement clinique en Chine...
Inventiva announces
Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China
May 25, 2023 16:00 ET | INVENTIVA
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm’s subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASHSino...
Correction: Inventiv
Correction: Inventiva publie ses résultats financiers préliminaires pour l’exercice 2022¹
February 14, 2023 17:00 ET | INVENTIVA
Daix (France), Long Island City (New York, Etats-Unis), le 14 février 2023 – Inventiva (Euronext Paris et Nasdaq : IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement...
Correction: Inventiv
Correction: Inventiva reports preliminary financial results for Full-Year 2022¹
February 14, 2023 17:00 ET | INVENTIVA
Daix (France), Long Island City (New York, United States), February 14, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...
Inventiva publie ses
Inventiva publie ses résultats financiers préliminaires pour l’exercice 2022¹
February 14, 2023 16:00 ET | INVENTIVA
Daix (France), Long Island City (New York, Etats-Unis), le 14 février 2023 – Inventiva (Euronext Paris et Nasdaq : IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement...
Inventiva reports pr
Inventiva reports preliminary financial results for Full-Year 2022¹
February 14, 2023 16:00 ET | INVENTIVA
Daix (France), Long Island City (New York, United States), February 14, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...
TIP_link_300x300.jpg
Intelligent Virtual Assistant Market Growth Worth $47.57 Bn Globally by 2028, Driven by High Adoption of Chatbots – Exclusive Report by The Insight Partners
November 16, 2022 08:47 ET | The Insight Partners
New York, Nov. 16, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Intelligent Virtual Assistant Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Service, Technology...
Inventiva annonce le
Inventiva annonce les résultats positifs de l’étude clinique « thorough » QT menée avec lanifibranor
December 06, 2021 16:00 ET | INVENTIVA
Etude  conduite chez 217 volontaires sains afin d’évaluer l’effet de lanifibranor sur l’intervalle QT/QTc et de soutenir la demande d’enregistrement d’un nouveau médicament (New Drug Application...